These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24107691)

  • 21. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience.
    Hayes HM; Dembo LG; Larbalestier R; O'Driscoll G
    Artif Organs; 2010 Sep; 34(9):703-6. PubMed ID: 20883388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-cardiac surgery in patients on long-term left ventricular assist device support.
    Morgan JA; Paone G; Nemeh HW; Henry SE; Gerlach B; Williams CT; Lanfear DE; Tita C; Brewer RJ
    J Heart Lung Transplant; 2012 Jul; 31(7):757-63. PubMed ID: 22425233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.
    Loyaga-Rendon RY; Hashim T; Tallaj JA; Acharya D; Holman W; Kirklin J; Pamboukian SV
    ASAIO J; 2015; 61(1):107-9. PubMed ID: 25232774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
    Stern DR; Kazam J; Edwards P; Maybaum S; Bello RA; D'Alessandro DA; Goldstein DJ
    J Card Surg; 2010 May; 25(3):352-6. PubMed ID: 20331479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anesthesia for noncardiac procedures for children with a Berlin Heart EXCOR Pediatric Ventricular Assist Device: a case series.
    Cave DA; Fry KM; Buchholz H
    Paediatr Anaesth; 2010 Jul; 20(7):647-59. PubMed ID: 20456063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.
    Slaughter MS; Pagani FD; Rogers JG; Miller LW; Sun B; Russell SD; Starling RC; Chen L; Boyle AJ; Chillcott S; Adamson RM; Blood MS; Camacho MT; Idrissi KA; Petty M; Sobieski M; Wright S; Myers TJ; Farrar DJ;
    J Heart Lung Transplant; 2010 Apr; 29(4 Suppl):S1-39. PubMed ID: 20181499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.
    Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G
    ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of general surgical problems in patients with left ventricular assist devices.
    McKellar SH; Morris DS; Mauermann WJ; Park SJ; Zietlow SP
    Surgery; 2012 Nov; 152(5):896-902. PubMed ID: 22575878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS
    J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Derived and displayed power consumption, flow, and pulsatility over a range of HeartMate II left ventricular assist device settings.
    Lund LH; Gabrielsen A; Tirén L; Hallberg A; El Karlsson K; Eriksson MJ
    ASAIO J; 2012; 58(3):183-90. PubMed ID: 22395117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved left ventricular unloading and circulatory support with synchronized pulsatile left ventricular assistance compared with continuous-flow left ventricular assistance in an acute porcine left ventricular failure model.
    Letsou GV; Pate TD; Gohean JR; Kurusz M; Longoria RG; Kaiser L; Smalling RW
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1181-8. PubMed ID: 20546799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
    Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of HeartWare Ventricular Assist System support in 141 patients: a single-centre experience.
    Wu L; Weng YG; Dong NG; Krabatsch T; Stepanenko A; Hennig E; Hetzer R
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):139-45. PubMed ID: 22858453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.